These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 19805176)
1. Distinct immune responses to transgene products from rAAV1 and rAAV8 vectors. Lu Y; Song S Proc Natl Acad Sci U S A; 2009 Oct; 106(40):17158-62. PubMed ID: 19805176 [TBL] [Abstract][Full Text] [Related]
2. Early interaction of adeno-associated virus serotype 8 vector with the host immune system following intramuscular delivery results in weak but detectable lymphocyte and dendritic cell transduction. Gernoux G; Guilbaud M; Dubreil L; Larcher T; Babarit C; Ledevin M; Jaulin N; Planel P; Moullier P; Adjali O Hum Gene Ther; 2015 Jan; 26(1):1-13. PubMed ID: 25333770 [TBL] [Abstract][Full Text] [Related]
3. Alpha1-antitrypsin gene therapy modulates cellular immunity and efficiently prevents type 1 diabetes in nonobese diabetic mice. Lu Y; Tang M; Wasserfall C; Kou Z; Campbell-Thompson M; Gardemann T; Crawford J; Atkinson M; Song S Hum Gene Ther; 2006 Jun; 17(6):625-34. PubMed ID: 16776571 [TBL] [Abstract][Full Text] [Related]
13. Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice. Nakai H; Fuess S; Storm TA; Muramatsu S; Nara Y; Kay MA J Virol; 2005 Jan; 79(1):214-24. PubMed ID: 15596817 [TBL] [Abstract][Full Text] [Related]
14. Serotype-specific Binding Properties and Nanoparticle Characteristics Contribute to the Immunogenicity of rAAV1 Vectors. Ferrand M; Da Rocha S; Corre G; Galy A; Boisgerault F Mol Ther; 2015 Jun; 23(6):1022-1033. PubMed ID: 25881000 [TBL] [Abstract][Full Text] [Related]
15. Ex vivo transduction and transplantation of bone marrow cells for liver gene delivery of alpha1-antitrypsin. Li H; Lu Y; Witek RP; Chang LJ; Campbell-Thompson M; Jorgensen M; Petersen B; Song S Mol Ther; 2010 Aug; 18(8):1553-8. PubMed ID: 20551917 [TBL] [Abstract][Full Text] [Related]
16. Circumventing cellular immunity by miR142-mediated regulation sufficiently supports rAAV-delivered OVA expression without activating humoral immunity. Xiao Y; Muhuri M; Li S; Qin W; Xu G; Luo L; Li J; Letizia AJ; Wang SK; Chan YK; Wang C; Fuchs SP; Wang D; Su Q; Nahid MA; Church GM; Farzan M; Yang L; Wei Y; Desrosiers RC; Mueller C; Tai PW; Gao G JCI Insight; 2019 May; 5(13):. PubMed ID: 31112525 [TBL] [Abstract][Full Text] [Related]
17. Transduction efficiency and immune response associated with the administration of AAV8 vector into dog skeletal muscle. Ohshima S; Shin JH; Yuasa K; Nishiyama A; Kira J; Okada T; Takeda S Mol Ther; 2009 Jan; 17(1):73-80. PubMed ID: 18941441 [TBL] [Abstract][Full Text] [Related]
18. Novel Combinatorial MicroRNA-Binding Sites in AAV Vectors Synergistically Diminish Antigen Presentation and Transgene Immunity for Efficient and Stable Transduction. Muhuri M; Zhan W; Maeda Y; Li J; Lotun A; Chen J; Sylvia K; Dasgupta I; Arjomandnejad M; Nixon T; Keeler AM; Manokaran S; He R; Su Q; Tai PWL; Gao G Front Immunol; 2021; 12():674242. PubMed ID: 33995418 [TBL] [Abstract][Full Text] [Related]
19. Recombinant adeno-associated virus vectors induce functionally impaired transgene product-specific CD8+ T cells in mice. Lin SW; Hensley SE; Tatsis N; Lasaro MO; Ertl HC J Clin Invest; 2007 Dec; 117(12):3958-70. PubMed ID: 18008010 [TBL] [Abstract][Full Text] [Related]
20. The complex and evolving story of T cell activation to AAV vector-encoded transgene products. Mays LE; Wilson JM Mol Ther; 2011 Jan; 19(1):16-27. PubMed ID: 21119617 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]